For citations:

Lesnyak O.M., Anoshenkova O.N., Barbarin I.N., Golubev G.Sh., Isaenko L.P., Knyazkova T.A., Nekrasova M.R., Nikitina N.V., Reznikova L.B., Semisotova E.F., Shandin A.N. Results of 2-year open multicenter observational study for efficacy, safety, tolerability and quality of life impact of zoledronic acid in women with postmenopausal osteoporosis in real-world settings in Russian Federation. Lechaschi Vrach. 2018;(3):9. (In Russ.)